Target Price | $26.52 |
Price | $4.80 |
Potential |
452.50%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Salarius Pharmaceuticals Inc 2026 .
The average Salarius Pharmaceuticals Inc target price is $26.52.
This is
452.50%
register free of charge
$27.30
468.75%
register free of charge
$26.26
447.08%
register free of charge
|
|
A rating was issued by 6 analysts: 0 Analysts recommend Salarius Pharmaceuticals Inc to buy, 3 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Salarius Pharmaceuticals Inc stock has an average upside potential 2026 of
452.50%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -86.91 | -9.35 |
81.15% | 89.24% | |
P/E | negative |
3 Analysts have issued a Salarius Pharmaceuticals Inc forecast for earnings per share. The average Salarius Pharmaceuticals Inc EPS is
This results in the following potential growth metrics and future valuations:
2024 | $-86.91 | 81.15% |
---|---|---|
2025 |
$-9.35
89.24%
Unlock
|
Current | -0.13 | 13.74% |
---|---|---|
2025 |
-0.51
283.17%
Unlock
|
Salarius Pharmaceuticals Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.